• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素 D 受体基因多态性、骨密度与绝经后骨质疏松症妇女骨折。

Vitamin D receptor gene polymorphisms, bone mineral density and fractures in postmenopausal women with osteoporosis.

机构信息

Department of Family Medicine, Poznań University of Medical Sciences, Przybyszewskiego Street 49, 60-355 Poznań, Poland.

出版信息

Mol Biol Rep. 2013 Jan;40(1):383-90. doi: 10.1007/s11033-012-2072-3. Epub 2012 Oct 17.

DOI:10.1007/s11033-012-2072-3
PMID:23070909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3518805/
Abstract

The goal of the study was to investigate the possibility of an association between polymorphisms and single alleles of BsmI, ApaI, TaqI of the vitamin D receptor (VDR) gene with bone mineral density (BMD) and prevalence of vertebral/non-vertebral fractures in a group of postmenopausal Polish women with osteoporosis. The study group comprised of 501 postmenopausal females with osteoporosis (mean age 66.4 ± 8.9), who were diagnosed on the basis of either the WHO criteria or self-reported history of low-energy fractures. The three polymorphisms were determined by PCR (polymerase chain reaction) and RFLP (restriction fragment length polymorphism). BMD at the lumbar spine and femoral neck was assessed by dual energy X-ray absorptiometry (DXA). 285 fractures were reported in the whole group (168 vertebral and 117 non-vertebral). Incidence of non-vertebral fractures was significantly higher in the carriers of single alleles a of ApaI, b of BsmI and T of TaqI VDR gene polymorphisms (p = 0.021, 0.032, 0.020, respectively). No significant associations between allelic variants of the studied polymorphisms and BMD or fracture incidence were found. (1).The presence of single alleles a,b and T of ApaI, BsmI, TaqI VDR gene polymorphisms respectively, might serve as an indicator of non-vertebral fractures. (2). Lack of association between the VDR gene polymorphisms and BMD suggests that VDR contributes to low-energy fractures also through other ways.

摘要

本研究旨在探讨维生素 D 受体(VDR)基因 BsmI、ApaI、TaqI 多态性和单等位基因与波兰骨质疏松绝经后妇女骨密度(BMD)和椎体/非椎体骨折发生率之间的相关性。研究组包括 501 例骨质疏松绝经后女性(平均年龄 66.4±8.9 岁),根据世界卫生组织(WHO)标准或低能量骨折的自述病史诊断为骨质疏松症。通过聚合酶链反应(PCR)和限制性片段长度多态性(RFLP)确定三种多态性。采用双能 X 线吸收法(DXA)测定腰椎和股骨颈的 BMD。全组报告 285 例骨折(168 例椎体骨折和 117 例非椎体骨折)。ApaI、BsmI 和 TaqI VDR 基因多态性单等位基因 a、b 和 T 的携带者中,非椎体骨折的发生率明显较高(分别为 p=0.021、0.032、0.020)。未发现研究多态性的等位基因变异与 BMD 或骨折发生率之间存在显著相关性。(1)ApaI、BsmI、TaqI VDR 基因多态性的单等位基因 a、b 和 T 的存在可能是非椎体骨折的指标。(2)VDR 基因多态性与 BMD 之间缺乏关联表明,VDR 也通过其他途径导致低能量骨折。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f65d/3518805/33ac6335fff1/11033_2012_2072_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f65d/3518805/33ac6335fff1/11033_2012_2072_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f65d/3518805/33ac6335fff1/11033_2012_2072_Fig1_HTML.jpg

相似文献

1
Vitamin D receptor gene polymorphisms, bone mineral density and fractures in postmenopausal women with osteoporosis.维生素 D 受体基因多态性、骨密度与绝经后骨质疏松症妇女骨折。
Mol Biol Rep. 2013 Jan;40(1):383-90. doi: 10.1007/s11033-012-2072-3. Epub 2012 Oct 17.
2
Association of vitamin D receptor gene polymorphism (TaqI and Apa1) with bone mineral density in North Indian postmenopausal women.维生素 D 受体基因多态性(TaqI 和 Apa1)与印度北部绝经后妇女骨密度的关系。
Gene. 2018 Jun 15;659:123-127. doi: 10.1016/j.gene.2018.03.052. Epub 2018 Mar 17.
3
Association Between Polymorphisms of VDR, COL1A1, and LCT genes and bone mineral density in Belarusian women with severe postmenopausal osteoporosis.维生素 D 受体、COL1A1 和 LCT 基因多态性与白俄罗斯绝经后严重骨质疏松症妇女骨密度的关系。
Medicina (Kaunas). 2013;49(4):177-84.
4
Prediction of bone mineral density from vitamin D receptor polymorphisms is uncertain in representative samples of Japanese Women. The Japanese Population-based Osteoporosis (JPOS) Study.在日本女性的代表性样本中,从维生素D受体多态性预测骨矿物质密度尚不确定。基于日本人群的骨质疏松症(JPOS)研究。
Int J Epidemiol. 2004 Oct;33(5):979-88. doi: 10.1093/ije/dyh245. Epub 2004 Sep 9.
5
Vitamin D receptor gene polymorphisms in a group of postmenopausal Turkish women: association wıth bone mineral density.维生素 D 受体基因多态性与一组绝经后土耳其女性的骨密度相关。
Climacteric. 2011 Jun;14(3):384-91. doi: 10.3109/13697137.2010.550973. Epub 2011 Mar 17.
6
Polymorphisms in VDR gene in Tunisian postmenopausal women are associated with osteopenia phenotype.突尼斯绝经后女性维生素D受体(VDR)基因多态性与骨质减少表型相关。
Climacteric. 2015;18(4):624-30. doi: 10.3109/13697137.2015.1007123. Epub 2015 Feb 18.
7
Vitamin D receptor gene polymorphisms, bone mass, bone loss and prevalence of vertebral fracture: differences in postmenopausal women and men.维生素D受体基因多态性、骨量、骨质流失与椎体骨折患病率:绝经后女性和男性的差异
Osteoporos Int. 1999;10(3):175-82. doi: 10.1007/s001980050213.
8
Vitamin D receptor gene polymorphisms, bone mineral density and bone turnover: FokI genotype is related to postmenopausal bone mass.维生素D受体基因多态性、骨密度与骨转换:FokI基因型与绝经后骨量相关。
Physiol Res. 2002;51(5):501-9.
9
The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis.常见维生素D受体基因变异与骨质疏松症之间的关联:一项参与者水平的荟萃分析。
Ann Intern Med. 2006 Aug 15;145(4):255-64. doi: 10.7326/0003-4819-145-4-200608150-00005.
10
The role of vitamin D receptor gene polymorphisms in the bone mineral density of Greek postmenopausal women with low calcium intake.维生素 D 受体基因多态性在低钙摄入的希腊绝经后妇女骨密度中的作用。
J Nutr Biochem. 2011 Aug;22(8):752-7. doi: 10.1016/j.jnutbio.2010.06.007. Epub 2010 Nov 5.

引用本文的文献

1
Genetics and Vitamin D Interactions in Osteoporosis: A Path to Precision Medicine.骨质疏松症中的遗传学与维生素D相互作用:精准医学之路
J Cell Mol Med. 2025 Aug;29(16):e70780. doi: 10.1111/jcmm.70780.
2
Genetic Influences and Targeted Treatments in Osteoporosis: A Systematic Review.骨质疏松症的遗传影响与靶向治疗:一项系统评价
Cureus. 2025 Jul 7;17(7):e87436. doi: 10.7759/cureus.87436. eCollection 2025 Jul.
3
Bone Fracture Incidence in Postmenopausal Women: Results of a 10 Year Follow Up in a RAC-OST-POL Study of rs1544410, rs7975232 and rs731236 Polymorphisms.

本文引用的文献

1
Insights into the genetics of osteoporosis from recent genome-wide association studies.从最近的全基因组关联研究中洞察骨质疏松症的遗传学。
Expert Rev Mol Med. 2011 Aug 26;13:e28. doi: 10.1017/S1462399411001980.
2
The effect of vitamin D receptor BsmI genotype on the response to osteoporosis treatment in postmenopausal women: a pilot study.维生素D受体BsmI基因多态性对绝经后妇女骨质疏松症治疗反应的影响:一项初步研究。
J Obstet Gynaecol Res. 2011 Oct;37(10):1415-22. doi: 10.1111/j.1447-0756.2011.01557.x. Epub 2011 Jun 9.
3
Recent insights into vitamin D and its receptor.
绝经后女性的骨折发生率:rs1544410、rs7975232和rs731236多态性的RAC - OST - POL研究10年随访结果
Nutrients. 2024 Nov 29;16(23):4146. doi: 10.3390/nu16234146.
4
Does the gene polymorphism influence the efficacy of denosumab therapy in postmenopausal osteoporosis?基因多态性是否影响绝经后骨质疏松症患者地舒单抗治疗的疗效?
Front Endocrinol (Lausanne). 2023 Jan 13;13:1063762. doi: 10.3389/fendo.2022.1063762. eCollection 2022.
5
Vitamin D Receptor Gene Polymorphisms Affect Osteoporosis-Related Traits and Response to Antiresorptive Therapy.维生素 D 受体基因多态性影响骨质疏松相关特征和抗吸收治疗反应。
Genes (Basel). 2023 Jan 11;14(1):193. doi: 10.3390/genes14010193.
6
Evaluation of Association Studies and an Updated Meta-Analysis of VDR Polymorphisms in Osteoporotic Fracture Risk.维生素D受体基因多态性与骨质疏松性骨折风险的关联研究评估及更新的荟萃分析
Front Genet. 2022 Jan 7;12:791368. doi: 10.3389/fgene.2021.791368. eCollection 2021.
7
Vitamin D receptor Bsm I polymorphism and osteoporosis risk in postmenopausal women: a meta-analysis from 42 studies.维生素D受体Bsm I基因多态性与绝经后女性骨质疏松症风险:一项来自42项研究的荟萃分析
Genes Nutr. 2020 Nov 25;15(1):20. doi: 10.1186/s12263-020-00679-9.
8
Association of vitamin D receptor ApaI gene polymorphism with osteoporosis susceptibility in postmenopausal Han Chinese women in Xinjiang.新疆绝经后汉族女性维生素D受体ApaI基因多态性与骨质疏松易感性的关系
Biomed Rep. 2018 Dec;9(6):483-490. doi: 10.3892/br.2018.1155. Epub 2018 Oct 3.
9
The interactions of physical activity, exercise and genetics and their associations with bone mineral density: implications for injury risk in elite athletes.体力活动、锻炼和遗传因素的相互作用及其与骨密度的关系:对精英运动员受伤风险的影响。
Eur J Appl Physiol. 2019 Jan;119(1):29-47. doi: 10.1007/s00421-018-4007-8. Epub 2018 Oct 30.
10
Clinical characteristics associated with bone mineral density improvement after 1-year alendronate/vitamin d3 or calcitriol treatment: Exploratory results from a phase 3, randomized, controlled trial on postmenopausal osteoporotic women in China.阿仑膦酸钠/维生素D3或骨化三醇治疗1年后与骨密度改善相关的临床特征:一项针对中国绝经后骨质疏松症女性的3期随机对照试验的探索性结果
Medicine (Baltimore). 2018 Aug;97(31):e11694. doi: 10.1097/MD.0000000000011694.
近期对维生素 D 及其受体的研究进展。
J Nephrol. 2011 May-Jun;24 Suppl 18:S30-7. doi: 10.5301/JN.2011.7767.
4
The role of vitamin D receptor gene polymorphisms in the bone mineral density of Greek postmenopausal women with low calcium intake.维生素 D 受体基因多态性在低钙摄入的希腊绝经后妇女骨密度中的作用。
J Nutr Biochem. 2011 Aug;22(8):752-7. doi: 10.1016/j.jnutbio.2010.06.007. Epub 2010 Nov 5.
5
A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution.一项 ChIP-seq 定义的维生素 D 受体结合的全基因组图谱:与疾病和进化的关联。
Genome Res. 2010 Oct;20(10):1352-60. doi: 10.1101/gr.107920.110. Epub 2010 Aug 24.
6
BsmI, TaqI, ApaI and FokI polymorphisms in the vitamin D receptor (VDR) gene and risk of fracture in Caucasians: a meta-analysis.维生素 D 受体 (VDR) 基因中 BsmI、TaqI、ApaI 和 FokI 多态性与白种人骨折风险的关系:荟萃分析。
Bone. 2010 Sep;47(3):681-6. doi: 10.1016/j.bone.2010.06.024. Epub 2010 Jun 28.
7
Risk factors for falls in community-dwelling older people: a systematic review and meta-analysis.社区居住老年人跌倒的风险因素:系统评价和荟萃分析。
Epidemiology. 2010 Sep;21(5):658-68. doi: 10.1097/EDE.0b013e3181e89905.
8
Vitamin D: extraskeletal health.维生素 D:骨骼外健康。
Endocrinol Metab Clin North Am. 2010 Jun;39(2):381-400, table of contents. doi: 10.1016/j.ecl.2010.02.016.
9
Bone CYP27B1 gene expression is increased with high dietary calcium and in mineralising osteoblasts.骨 CYP27B1 基因表达随高膳食钙和矿化成骨细胞而增加。
J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):71-5. doi: 10.1016/j.jsbmb.2010.03.021. Epub 2010 Mar 15.
10
Human genetics of osteoporosis.骨质疏松症的人类遗传学
Best Pract Res Clin Endocrinol Metab. 2008 Oct;22(5):723-35. doi: 10.1016/j.beem.2008.08.007.